The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Whether a discrete vascular action of insulin in skeletal muscle integrally participates in insulin‐mediated glucose disposal has been extensively examined but remains a contentious issue. Here, we review some of the data both supporting and questioning the role of insulin‐mediated increases in limb blood flow in glucose metabolism. We advance the hypothesis that controversy has arisen, at least in part, from a failure to recognize that insulin exerts at least three separate actions on the peripheral vasculature, each with its own characteristic dose and time responsiveness. We summarize how, viewed in this manner, certain points of contention can be resolved. We also advance the hypothesis that an action on the precapillary arteriole may play the dominant role in mediating perfusion‐dependent effects of insulin on glucose metabolism in muscle. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 12×
“For example, there is evidence from the perfused rat hindlimb that carbachol (an agent similar to methacholine) dilates serotonin-constricted sites and overcomes serotonin-induced inhibition of IMGU [65].”
InfluentialLaakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745 · cited 2×
“mediated NO release is dependent on NOS [69], insulin receptor tyrosine kinase [69], PI3 kinase [67,69], and Akt”
BackgroundZeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · cited 16×
“More recently, we have examined the effect of more specific blockade of insulininduced dilation of resistance vessels and microvascular recruitment using L-NAME, a competitive inhibitor of nitric oxide synthase (NOS).”
BackgroundInfluentialImpaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · Diabetes · doi:10.2337/diab.41.9.1076 · Cited by 470
Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm
Cardillo, C., Nambi, S. S., Kilcoyne, C. M., Choucair, W. K., Katz, A., Quon, M. J., & Panza, J. A. (1999) · Circulation · doi:10.1161/01.cir.100.8.820 · Cited by 301
Kapur, S., Bédard, S., Marcotte, B., Côté, C. H., & Marette, A. (1997) · Diabetes · doi:10.2337/diab.46.11.1691 · Cited by 225 · cited 1×
“[37] found no effect on either basal or”
BackgroundEffects of low‐dose l‐arginine on insulin‐mediated vasodilatation and insulin sensitivity
WASCHER, T. C., GRAIER, W. F., DITTRICH, P., HUSSAIN, M. A., BAHADORI, B., WALLNER, S., & TOPLAK, H. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1730718.x · Cited by 87 · cited 1×
“Interestingly, in another study, L-arginine did not increase blood flow in healthy volunteers but did on obese and patients with type 2 diabetes; however, the infusion had positive effects on glucose uptake in all groups [42].”
Result
Cited by
The Vascular Endothelium and Human Diseases
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,467
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Versari, D., Daghini, E., Virdis, A., Ghiadoni, L., & Taddei, S. (2009) · Diabetes Care · doi:10.2337/dc09-s330 · Cited by 516
Obesity Blunts Insulin-Mediated Microvascular Recruitment in Human Forearm Muscle
Clerk, L. H., Vincent, M. A., Jahn, L. A., Liu, Z., Lindner, J. R., & Barrett, E. J. (2006) · Diabetes · doi:10.2337/db05-1373 · Cited by 300
Self-citationFujita, S., Rasmussen, B. B., Cadenas, J. G., Drummond, M. J., Glynn, E. L., Sattler, F. R., & Volpi, E. (2007) · Diabetes · doi:10.2337/db06-1566 · Cited by 224
“This occurs because an increased blood flow reduces the arteriovenous glucose gradient and allows for a more uniform exposure of all muscle tissue to adequate blood glucose concentrations necessary to sustain the higher rate of uptake (41).”
BackgroundFujita, S., Glynn, E. L., Timmerman, K. L., Rasmussen, B. B., & Volpi, E. (2009) · Diabetologia · doi:10.1007/s00125-009-1430-8 · Cited by 164
Timmerman, K. L., Lee, J. L., Fujita, S., Dhanani, S., Dreyer, H. C., Fry, C. S., Drummond, M. J., Sheffield-Moore, M., Rasmussen, B. B., & Volpi, E. (2010) · Diabetes · doi:10.2337/db10-0415 · Cited by 149
“A recent theory (42) suggests, in fact, that increased perfusion enhances only maximal glucose uptake, when large arteriovenous glucose gradients occur.”
Glucagon-like peptide-1 receptor agonists and muscle mass effects
Ceasovschih, A., Asaftei, A., Lupo, M. G., Kotlyarov, S., Bartušková, H., Balta, A., Sorodoc, V., Sorodoc, L., & Banach, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107927 · Cited by 64
Wang, N., Ko, S.-H., Chai, W., Li, G., Barrett, E. J., Tao, L., Cao, W., & Liu, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00414.2010 · Cited by 28
Self-citation
Metadata
- Authors
- Clerk, L. H., Vincent, M. A., Lindner, J. R., Clark, M. G., Rattigan, S., & Barrett, E. J.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2003-11-18
- Volume
- 20
- Issue
- 1
- Pages
- 3-12
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2051303256
- Cited by
- 104
- References
- 8
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.